Suppr超能文献

核黄素合酶的产物及鲁米诺合酶的核糖醇氨基嘧啶底物的S-核苷类似物的合成与酶抑制活性

Synthesis and enzyme inhibitory activity of the s-nucleoside analogue of the ribitylaminopyrimidine substrate of lumazine synthase and product of riboflavin synthase.

作者信息

Talukdar Arindam, Illarionov Boris, Bacher Adelbert, Fischer Markus, Cushman Mark

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmaceutical Sciences, and Purdue Cancer Center, Purdue University, West Lafayette, IN 47907, USA.

出版信息

J Org Chem. 2007 Sep 14;72(19):7167-75. doi: 10.1021/jo0709495. Epub 2007 Aug 16.

Abstract

Lumazine synthase and riboflavin synthase catalyze the last two steps in the biosynthesis of riboflavin. To obtain structural and mechanistic probes of these two enzymes, as well as inhibitors of potential value as antibiotics, a sulfur analogue of the pyrimidine substrate of the lumazine synthase-catalyzed reaction and product of the riboflavin synthase-catalyzed reaction was designed. Facile syntheses of the S-nucleoside 5-amino-6-(D-ribitylthio)pyrimidine-2,4(1H,3H)-dione hydrochloride (15) and its nitro precursor 5-nitro-6-(D-ribitylthio)pyrimidine-2,4(1H,3H)-dione (14) are described. These compounds were tested against lumazine synthase and riboflavin synthase obtained from a variety of microorganisms. Compounds 14 and 15 were found to be inhibitors of both riboflavin synthase and lumazine synthase. Compound 14 is an inhibitor of Bacillus subtilis lumazine synthase (Ki 26 microM), Schizosaccharomyces pombe lumazine synthase (Ki 2.0 microM), Mycobacterium tuberculosis lumazine synthase (Ki 11 microM), Escherichia coli riboflavin synthase (Ki 2.7 microM), and Mycobacterium tuberculosis riboflavin synthase (Ki 0.56 muM), while compound 15 is an inhibitor of B. subtilis lumazine synthase (Ki 2.6 microM), S. pombe lumazine synthase (Ki 0.16 microM), M. tuberculosis lumazine synthase (Ki 31 microM), E. coli riboflavin synthase (Ki 47 microM), and M. tuberculosis riboflavin synthase (Ki 2.5 microM).

摘要

核黄素合酶和核黄素合成酶催化核黄素生物合成的最后两步。为了获得这两种酶的结构和机制探针,以及具有抗生素潜在价值的抑制剂,设计了一种核黄素合酶催化反应的嘧啶底物和核黄素合成酶催化反应产物的硫类似物。描述了S-核苷5-氨基-6-(D-核糖硫基)嘧啶-2,4(1H,3H)-二酮盐酸盐(15)及其硝基前体5-硝基-6-(D-核糖硫基)嘧啶-2,4(1H,3H)-二酮(14)的简便合成方法。这些化合物针对从多种微生物中获得的核黄素合酶和核黄素合成酶进行了测试。发现化合物14和15都是核黄素合成酶和核黄素合酶的抑制剂。化合物14是枯草芽孢杆菌核黄素合酶(Ki 26 microM)、粟酒裂殖酵母核黄素合酶(Ki 2.0 microM)、结核分枝杆菌核黄素合酶(Ki 11 microM)、大肠杆菌核黄素合成酶(Ki 2.7 microM)和结核分枝杆菌核黄素合成酶(Ki 0.56 microM)的抑制剂,而化合物15是枯草芽孢杆菌核黄素合酶(Ki 2.6 microM)、粟酒裂殖酵母核黄素合酶(Ki 0.16 microM)、结核分枝杆菌核黄素合酶(Ki 31 microM)、大肠杆菌核黄素合成酶(Ki 47 microM)和结核分枝杆菌核黄素合成酶(Ki 2.5 microM)的抑制剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验